We are live on ! Find out more
DSC

Duncker Streett & Co Portfolio holdings

AUM $526M
1-Year Est. Return 22.2%
This Fund
S&P 500
This Quarter Est. Return
-0.66%
1 Year Est. Return
+22.2%
3 Year Est. Return
+74.69%
5 Year Est. Return
+94.09%
10 Year Est. Return
+300.66%
AUM
$287M
AUM Growth
-$18.6M
Cap. Flow
-$15.8M
Cap. Flow %
-5.51%
Top 10 Hldgs %
17.25%
Holding
648
New
21
Increased
114
Reduced
144
Closed
19

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.35M
2
MA icon
Mastercard
MA
+$1.32M
3
BAC icon
Bank of America
BAC
+$772K
4
PXD
Pioneer Natural Resource Co.
PXD
+$583K
5
DHR icon
Danaher
DHR
+$560K

Sector Composition

Rank Sector Weight
1 Healthcare 19.4%
2 Financials 10.84%
3 Industrials 10.56%
4 Technology 9.65%
5 Energy 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$631B
$8.46M 2.95%
101,681
-15,675
-13% -$1.35M
DHR icon
2
Danaher
DHR
$141B
$5.62M 1.96%
97,698
-9,780
-9% -$560K
AAPL icon
3
Apple
AAPL
$4.99T
$5.32M 1.85%
169,528
-7,756
-4% -$248K
MA icon
4
Mastercard
MA
$496B
$5.19M 1.81%
55,538
-14,349
-21% -$1.32M
GE icon
5
GE Aerospace
GE
$376B
$4.76M 1.66%
37,399
-3,541
-9% -$459K
TMO icon
6
Thermo Fisher Scientific
TMO
$214B
$4.51M 1.57%
34,782
-3,900
-10% -$508K
PG icon
7
Procter & Gamble
PG
$352B
$4.13M 1.44%
52,820
-21
-0% -$1.69K
ABBV icon
8
AbbVie
ABBV
$468B
$3.9M 1.36%
58,044
+1,808
+3% +$118K
IBM icon
9
IBM
IBM
$212B
$3.83M 1.34%
24,641
-1,605
-6% -$258K
KMI icon
10
Kinder Morgan
KMI
$70.3B
$3.77M 1.31%
98,271
-5,266
-5% -$220K
AGN
11
DELISTED
Allergan plc
AGN
$3.55M 1.24%
11,684
-1,380
-11% -$412K
IGSB icon
12
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$3.48M 1.21%
66,134
-396
-0.6% -$20.9K
ECL icon
13
Ecolab
ECL
$78.9B
$3.47M 1.21%
30,708
-4,581
-13% -$527K
HSIC icon
14
Henry Schein
HSIC
$9.7B
$3.43M 1.2%
61,539
-9,690
-14% -$536K
VFC icon
15
VF Corp
VFC
$6.93B
$3.42M 1.19%
52,022
-637
-1% -$43.1K
CVS icon
16
CVS Health
CVS
$138B
$3.11M 1.08%
29,640
-2,850
-9% -$291K
NKE icon
17
Nike
NKE
$64B
$3.06M 1.07%
56,654
-2,400
-4% -$123K
BMY icon
18
Bristol-Myers Squibb
BMY
$130B
$3.04M 1.06%
45,725
+3
+0% +$198
PFE icon
19
Pfizer
PFE
$143B
$3.04M 1.06%
95,510
-8,097
-8% -$264K
IGIB icon
20
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$2.95M 1.03%
54,188
-70
-0.1% -$3.84K
ITW icon
21
Illinois Tool Works
ITW
$85.8B
$2.93M 1.02%
31,894
-3,497
-10% -$333K
JNJ icon
22
Johnson & Johnson
JNJ
$650B
$2.88M 1.01%
29,590
-143
-0.5% -$14.3K
SYK icon
23
Stryker
SYK
$132B
$2.87M 1%
29,970
-2,800
-9% -$265K
MRK icon
24
Merck
MRK
$325B
$2.84M 0.99%
52,246
-6,087
-10% -$341K
ABT icon
25
Abbott
ABT
$188B
$2.77M 0.97%
56,546
-395
-0.7% -$19K

Similar funds

Duncker Streett & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Duncker Streett & Co held 648 positions worth $287M, down 6.1% from $306M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Duncker Streett & Co withdrew a net $15.8M in Q2 2015, closing 19 positions and reducing 144 holdings. Its most notable exit was INTEGRYS ENERGY GROUP INC COM (USA), an estimated $195K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.

Against the trend, Duncker Streett & Co opened a new position in EOG Resources worth $718K.

  • Duncker Streett & Co's largest Q2 2015 buy was EOG Resources: 8,200 shares worth $718K.
  • Duncker Streett & Co added most to Vanguard FTSE Europe ETF in Q2 2015, an estimated $369K increase.
  • Duncker Streett & Co's biggest Q2 2015 reduction was ExxonMobil, cutting an estimated $1.35M.
  • Duncker Streett & Co fully exited INTEGRYS ENERGY GROUP INC COM (USA) in Q2 2015, selling an estimated $195K.
  • Duncker Streett & Co's ten largest holdings make up 17% of its $287M portfolio in Q2 2015.
  • Duncker Streett & Co opened 21 new positions and closed 19 in Q2 2015.
  • Duncker Streett & Co's portfolio value fell 6.1% quarter-over-quarter to $287M.

Based on Duncker Streett & Co's 13F filing for Q2 2015, filed 20 Jul 2015.